North America’s medical devices industry saw a drop of 7.29% in deal activity during August 2021, when compared with the last 12-month average, led by 22C Capital, Insight Partners and Nordic Capital’s $7.3bn private equity deal with Inovalon Holdings, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.


A total of 89 medical devices industry deals worth $12.9bn were announced for the region in August 2021, against the 12-month average of 96 deals.

Of all the deal types, venture financing saw most activity in August 2021 with 60 transactions, representing a 67.4% share for the region.

In second place was M&A with 20 deals, followed by private equity deals with nine transactions, respectively capturing a 22.5% and 10.1% share of the overall deal activity for the month.

In terms of value of deals, private equity was the leading category in North America’s medical devices industry with $7.59bn, while M&A and venture financing deals totalled $4.11bn and $1.24bn, respectively.

North America medical devices industry deals in August 2021: Top deals

The top five medical devices deals accounted for 88.6% of the overall value during August 2021.

The combined value of the top five medical devices deals stood at $11.46bn, against the overall value of $12.9bn recorded for the month.

The top five medical devices industry deals of August 2021 tracked by GlobalData were:

1) 22C Capital,Insight Partners and Nordic Capital $7.3bn private equity deal with Inovalon Holdings

2) The $2.5bn acquisition of Smiths Medical by Trulli Bidco

3) Medtronic $1.1bn acquisition deal with Intersect ENT

4) The $340m acquisition of BioVision by Abcam

5) Adams Street Partners,Battery Ventures,Coatue Management,ICONIQ Growth and Sierra Ventures $220m venture financing deal with Reify Health